A TNF-Regulated Recombinatorial Macrophage Immune Receptor Implicated in Granuloma Formation in Tuberculosis
Macrophages play a central role in host defense against mycobacterial infection and anti- TNF therapy is associated with granuloma disorganization and reactivation of tuberculosis in humans. Here, we provide evidence for the presence of a T cell receptor (TCR) αβ based recombinatorial immune receptor in subpopulations of human and mouse monocytes and macrophages. In vitro, we find that the macrophage-TCRαβ induces the release of CCL2 and modulates phagocytosis. TNF blockade suppresses macrophage-TCRαβ expression. Infection of macrophages from healthy individuals with mycobacteria triggers formation of clusters that express restricted TCR Vβ repertoires. In vivo, TCRαβ bearing macrophages abundantly accumulate at the inner host-pathogen contact zone of caseous granulomas from patients with lung tuberculosis. In chimeric mouse models, deletion of the variable macrophage-TCRαβ or TNF is associated with structurally compromised granulomas of pulmonary tuberculosis even in the presence of intact T cells. These results uncover a TNF-regulated recombinatorial immune receptor in monocytes/macrophages and demonstrate its implication in granuloma formation in tuberculosis.
Vyšlo v časopise:
A TNF-Regulated Recombinatorial Macrophage Immune Receptor Implicated in Granuloma Formation in Tuberculosis. PLoS Pathog 7(11): e32767. doi:10.1371/journal.ppat.1002375
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1002375
Souhrn
Macrophages play a central role in host defense against mycobacterial infection and anti- TNF therapy is associated with granuloma disorganization and reactivation of tuberculosis in humans. Here, we provide evidence for the presence of a T cell receptor (TCR) αβ based recombinatorial immune receptor in subpopulations of human and mouse monocytes and macrophages. In vitro, we find that the macrophage-TCRαβ induces the release of CCL2 and modulates phagocytosis. TNF blockade suppresses macrophage-TCRαβ expression. Infection of macrophages from healthy individuals with mycobacteria triggers formation of clusters that express restricted TCR Vβ repertoires. In vivo, TCRαβ bearing macrophages abundantly accumulate at the inner host-pathogen contact zone of caseous granulomas from patients with lung tuberculosis. In chimeric mouse models, deletion of the variable macrophage-TCRαβ or TNF is associated with structurally compromised granulomas of pulmonary tuberculosis even in the presence of intact T cells. These results uncover a TNF-regulated recombinatorial immune receptor in monocytes/macrophages and demonstrate its implication in granuloma formation in tuberculosis.
Zdroje
1. JanewayCAJrMedzhitovR 2002 Innate immune recognition. Annu Rev Immunol 20 197 216
2. GlaziouPFloydKRaviglioneM 2009 Global burden and epidemiology of tuberculosis. Clin Chest Med 30 621 636, vii
3. MillerEAErnstJD 2008 Illuminating the black box of TNF action in tuberculous granulomas. Immunity 29 175 177
4. KaufmannSH 2006 Tuberculosis: back on the immunologists' agenda. Immunity 24 351 357
5. KeaneJGershonSWiseRPMirabile-LevensEKasznicaJ 2001 Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 345 1098 1104
6. IzzoAANorthRJ 1992 Evidence for an alpha/beta T cell-independent mechanism of resistance to mycobacteria. Bacillus-Calmette-Guerin causes progressive infection in severe combined immunodeficient mice, but not in nude mice or in mice depleted of CD4+ and CD8+ T cells. J Exp Med 176 581 586
7. SaundersBMBriscoeHBrittonWJ 2004 T cell-derived tumour necrosis factor is essential, but not sufficient, for protection against Mycobacterium tuberculosis infection. Clin Exp Immunol 137 279 287
8. SaundersBMTranSRuulsSSedgwickJDBriscoeH 2005 Transmembrane TNF is sufficient to initiate cell migration and granuloma formation and provide acute, but not long-term, control of Mycobacterium tuberculosis infection. J Immunol 174 4852 4859
9. PuellmannKKaminskiWEVogelMNebeTCSchröderJ 2006 From the cover: A variable immunoreceptor in a subpopulation of human neutrophils. Proc Natl Acad Sci USA 103 14441 14446
10. PuellmannKBehamAWKaminskiWE 2006 Cytokine storm and an anti-CD28 monoclonal antibody. N Engl J Med 355 2592 2593; author reply 2593–2594
11. LegrandFDrissVWoerlyGLoiseauSHermannE 2009 A functional gammadeltaTCR/CD3 complex distinct from gammadeltaT cells is expressed by human eosinophils. PLoS One 4 e5926
12. KzhyshkowskaJGratchevASchmuttermaierCBrundiersHKrusellL 2008 Alternatively activated macrophages regulate extracellular levels of the hormone placental lactogen via receptor-mediated uptake and transcytosis. J Immunol 180 3028 3037
13. van DongenJJLangerakAWBruggemannMEvansPAHummelM 2003 Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 17 2257 2317
14. GeneveeCDiuANieratJCaignardADietrichPY 1992 An experimentally validated panel of subfamily-specific oligonucleotide primers (V alpha 1-w29/V beta 1-w24) for the study of human T cell receptor variable V gene segment usage by polymerase chain reaction. Eur J Immunol 22 1261 1269
15. VirchowR 1856 Aus dem pathologisch-anatomischen Curse. Wien Med Wschr 51 811 812
16. GardamMAKeystoneECMenziesRMannersSSkameneE 2003 Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management. Lancet Infect Dis 3 148 155
17. WallisRS 2008 Tumour necrosis factor antagonists: structure, function, and tuberculosis risks. Lancet Infect Dis 8 601 611
18. TraceyDKlareskogLSassoEHSalfeldJGTakPP 2008 Tumor necrosis factor antagonist mechanisms of action: a comprehensive review. Pharmacol Ther 117 244 279
19. WallisRSKyambaddePJohnsonJLHorterLKittleR 2004 A study of the safety, immunology, virology, and microbiology of adjunctive etanercept in HIV-1-associated tuberculosis. Aids 18 257 264
20. OuchidaRYamasakiSHikidaMMasudaKKawamuraK 2008 A lysosomal protein negatively regulates surface T cell antigen receptor expression by promoting CD3zeta-chain degradation. Immunity 29 33 43
21. GastmanBRJohnsonDEWhitesideTLRabinowichH 1999 Caspase-mediated degradation of T-cell receptor zeta-chain. Cancer Res 59 1422 1427
22. BeanAGRoachDRBriscoeHFranceMPKornerH 1999 Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin. J Immunol 162 3504 3511
23. BellJJBhandoolaA 2008 The earliest thymic progenitors for T cells possess myeloid lineage potential. Nature 452 764 767
24. SunJCBeilkeJNLanierLL 2009 Adaptive immune features of natural killer cells. Nature 457 557 561
25. WadaHMasudaKSatohRKakugawaKIkawaT 2008 Adult T-cell progenitors retain myeloid potential. Nature 452 768 772
26. LiJBarredaDRZhangYABoshraHGelmanAE 2006 B lymphocytes from early vertebrates have potent phagocytic and microbicidal abilities. Nat Immunol 7 1116 1124
27. MillerEAErnstJD 2009 Anti-TNF immunotherapy and tuberculosis reactivation: another mechanism revealed. J Clin Invest 119 1079 1082
28. KzhyshkowskaJGratchevAMartensJHPervushinaOMamidiS 2004 Stabilin-1 localizes to endosomes and the trans-Golgi network in human macrophages and interacts with GGA adaptors. J Leukoc Biol 76 1151 1161
29. KaminskiWELindahlPLinNBroudyVCrosbyJ 2001 Basis of hematopoietic defects in platelet-derived growth factor (PDGF)-B and PDGF beta-receptor null mice. Blood 97 1990 1998
30. 2008 WMA Declaration of Helsinki - Ethical Principles for Medical Research Involving Human Subjects www.wma.net/en/30publications/10policies/b3/index.html
31. FindeisenPNeumaierM 2009 Mass spectrometry-based clinical proteomics profiling: current status and future directions. Expert Rev Proteomics 6 457 459
32. BienvenutWVDeonCPasquarelloCCampbellJMSanchezJC 2002 Matrix-assisted laser desorption/ionization-tandem mass spectrometry with high resolution and sensitivity for identification and characterization of proteins. Proteomics 2 868 876
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2011 Číslo 11
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- Multiple Candidate Effectors from the Oomycete Pathogen Suppress Host Plant Immunity
- The Splicing Factor Proline-Glutamine Rich (SFPQ/PSF) Is Involved in Influenza Virus Transcription
- A TNF-Regulated Recombinatorial Macrophage Immune Receptor Implicated in Granuloma Formation in Tuberculosis
- SH3 Domain-Mediated Recruitment of Host Cell Amphiphysins by Alphavirus nsP3 Promotes Viral RNA Replication